BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2492798)

  • 1. The laboratory diagnosis of lupus anticoagulants.
    Lazarchick J; Kizer J
    Arch Pathol Lab Med; 1989 Feb; 113(2):177-80. PubMed ID: 2492798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The laboratory heterogeneity of lupus anticoagulants.
    Triplett DA; Brandt JT; Maas RL
    Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
    Brandt JT; Triplett DA; Musgrave K; Orr C
    Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
    Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
    Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom time.
    Brandt JT; Triplett DA
    Arch Pathol Lab Med; 1989 Dec; 113(12):1376-8. PubMed ID: 2511818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of recently described tests for detection of the lupus anticoagulant.
    Forastiero RR; Cerrato GS; Carreras LO
    Thromb Haemost; 1994 Nov; 72(5):728-33. PubMed ID: 7900080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative sensitivity of different tests in the detection of low titer lupus anticoagulants.
    Lesperance B; David M; Rauch J; Infante-Rivard C; Rivard GE
    Thromb Haemost; 1988 Oct; 60(2):217-9. PubMed ID: 3146139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants.
    Alving BM; Barr CF; Johansen LE; Tang DB
    Thromb Haemost; 1992 Jun; 67(6):672-8. PubMed ID: 1509408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus anticoagulants in children.
    Singh AK; Rao KP; Kizer J; Lazarchick J
    Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing strategies for diagnosing lupus anticoagulant: decision analysis.
    Segal JB; Lehmann HP; Petri M; Mueller L; Kickler TS
    Am J Hematol; 2002 Jul; 70(3):195-205. PubMed ID: 12111765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lupus anticoagulant neutralization procedure using the patient's own platelets.
    Carroll P; Ray M; Just S; Hawson G
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):523-7. PubMed ID: 7841308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of lupus-like anticoagulants by an enzyme-linked immunosorbent assay using a partial thromboplastin as antigen; a comparative study.
    Arnout J; Huybrechts E; Vanrusselt M; Falcon C; Vermylen J
    Thromb Haemost; 1990 Aug; 64(1):26-31. PubMed ID: 2125756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for the lupus anticoagulant.
    Triplett DA
    Ric Clin Lab; 1989; 19(4):379-89. PubMed ID: 2517352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.